Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Patients with this syndrome can have different responses and worsening resistance to treatment over time.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.